Xianghu He

Dr. Xianghu He


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
XYXue‐Tao Yan
Xue‐Tao Yan
JLJing‐Min Lu
Jing‐Min Lu
YWYu Wang
Yu Wang
XCXiao‐Li Cheng
Xiao‐Li Cheng
XHXianghu He
Xianghu He
YWYan‐Lin Wang
Yan‐Lin Wang

18 November 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
XYXue‐Tao Yan
Xue‐Tao Yan
YZYing Zhao
Ying Zhao
XCXiao‐Li Cheng
Xiao‐Li Cheng
XHXianghu He
Xianghu He
YWYu Wang
Yu Wang
YWYan‐Lin Wang
Yan‐Lin Wang

11 July 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
TJTuo Ji
Tuo Ji
MCMeng Chen
Meng Chen
YLYinyin Liu
Yinyin Liu
HJHaixing Jiang
Haixing Jiang
NLNa Li
Na Li
XHXianghu He
Xianghu He

22 June 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MCMeng Chen
Meng Chen
XYXue-Tao Yan
Xue-Tao Yan
LYLi Ye
Li Ye
JTJun-Jiao Tang
Jun-Jiao Tang
ZZZong-Ze Zhang
Zong-Ze Zhang
XHXianghu He
Xianghu He
Intestinal ischemia/reperfusion (I/R) is a clinical emergency, which often causes lung injury with high morbidity and mortality. Although dexmedetomidine has been identified to have a protective effect on lung injury caused by intestinal I/R, its specific mechanism is still elucidated. In recent years, the cannabinoid (CB2) receptor pathway has been found to be involved in I/R injury of some organs. In the current study, we investigated whether the CB2receptor pathway contributes to the protective effect of dexmedetomidine on the intestinal I/R-induced lung injury in rats. Dexmedetomidine treatment upregulated the expression of CB2receptor and suppressed the I/R-induced increases in lung injury scores, inflammatory cell infiltration, lung wet/dry ratio, MPO activity, MDA level, inflammatory cytokines, and caspase-3 expression while augmenting SOD activity and Bcl-2 expression, indicating attenuation of lung injury. Dexmedetomidine treatment also increased the expression of Akt. The protective effects of dexmedetomidine treatment were reversed by the CB2receptor antagonist AM630 or the PI3K inhibitor wortmannin. And the CB2receptor antagonist AM630 also downregulated the expression of Akt. Thus, our findings suggest that treatment with dexmedetomidine provides a protective role against lung injury caused by intestinal I/R in rats, possibly due to the upregulation of the CB2receptor, followed by the activation of the PI3K/Akt pathway.

27 November 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
XYXue‐Tao Yan
Xue‐Tao Yan
YXYong Xu
Yong Xu
XCXiao‐Li Cheng
Xiao‐Li Cheng
XHXianghu He
Xianghu He
YWYu Wang
Yu Wang
YWYan‐Lin Wang
Yan‐Lin Wang

1 March 2014 in Journal of Surgical Research
Verified
Journal Article
Closed access
XHXianghu He
Xianghu He
XYXue-Tao Yan
Xue-Tao Yan
YWYan-Lin Wang
Yan-Lin Wang
CWCheng-Yao Wang
Cheng-Yao Wang
ZZZong-Ze Zhang
Zong-Ze Zhang
JZJia Zhan
Jia Zhan